|
|
|
|
| LEADER |
01851nmm a2200397 u 4500 |
| 001 |
EB002176979 |
| 003 |
EBX01000000000000001314513 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
231006 ||| eng |
| 100 |
1 |
|
|a Abdelalim, Essam M.
|
| 245 |
0 |
0 |
|a Human pluripotent stem cells as a platform for precision medicine in diabetes
|h Elektronische Ressource
|c Essam M. Abdelalim
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2023, 2023
|
| 300 |
|
|
|a 1 streaming video file (52 min.)
|b color, sound
|
| 505 |
0 |
|
|a Contents: Monogenic diabetes -- Pluripotent Stem Cells (PSCs) -- iPSCs derived from a patient with diabetes -- Generation of pancreatic cells for cell therapy -- Clinical trial using encapsulated hESC-derived pancreatic progenitors -- Clinical trial using stem cell-derived insulin-producing pancreatic islets -- Psoriasis and insulin resistance -- FOXA2 in liver development -- Hepatocyte model
|
| 653 |
|
|
|a Precision Medicine
|
| 653 |
|
|
|a Induced Pluripotent Stem Cells
|
| 653 |
|
|
|a Psoriasis
|
| 653 |
|
|
|a Insulin
|
| 653 |
|
|
|a Stem cells
|
| 653 |
|
|
|a Cellular therapy
|
| 653 |
|
|
|a Diabetes / Treatment
|
| 653 |
|
|
|a Human Embryonic Stem Cells
|
| 653 |
|
|
|a Clinical Trials as Topic
|
| 653 |
|
|
|a Diabetes Mellitus / immunology
|
| 653 |
|
|
|a Hepatocytes
|
| 653 |
|
|
|a Diabetes Mellitus / therapy
|
| 653 |
|
|
|a Cell- and Tissue-Based Therapy
|
| 653 |
|
|
|a Pluripotent Stem Cells / therapeutic use
|
| 653 |
|
|
|a Personalized medicine
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a The biomedical & life sciences collection
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/5410
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|